Seth Lederman

CNS pipeline · person

Seth Lederman, MD

Co-Founder, Chief Executive Officer and Chairman of Tonix Pharmaceuticals, serving as President, CEO, Chairman and a Director since October 2011. Founded the Tonix Pharmaceuticals subsidiary in 2007 and is an inventor on key patents underlying the company's programs, including TNX-102 SL. Formerly an Associate Professor at Columbia University (1996-2017), where he discovered and characterized CD40-ligand (CD154). Received a BA in Chemistry from Princeton University and his MD from Columbia University.

  • 1 company

Courtesy Tonix Pharmaceuticals

Current roles

Appears with

People sharing a company with Seth.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.